ArticleOpen forum infectious diseases2025
Acute and Postacute Health Care Utilization and Costs After Dengue Infection: A Population-Based Cohort Study.
Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Economic Burden of Inappropriate Antibiotic Prescribing Attributable to Dengue in Singapore.PharmacoEconomics - open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Emerging evidence suggests that postacute sequelae may arise following dengue infection. There has been no quantification of the risk and burden of acute and postacute health care utilization and cost due to dengue. Methods: We utilized national notification databases from Singapore to construct cohorts of adults first infected with dengue. We compared 55 870 dengue cases with 3 072 309 population-based controls. We estimate excess risks, rates, and burdens of any all-cause inpatient hospital utilization, length of stay in inpatient settings or number of unique hospital inpatient admissions, any all-cause intensive care unit utilization, length of stay in the intensive care unit (ICU) or number of unique ICU admissions, any all-cause emergency department utilization and total number of unique emergency department visits, and any hospitalization costs incurred and excess total hospitalization costs incurred by contrasting dengue patients with population-based controls 0-30 days and 31-300 days following infection. Results: Dengue patients had elevated risk of emergency department visits, inpatient admissions, and incurring any inpatient costs across the acute and postacute periods. Among patients who had any inpatient admissions, dengue patients were associated with 11.938-fold (95% CI, 10.308-14.179) higher rates of unique inpatient visits, 15.852-fold (95% CI, 11.868-23.861) longer lengths of stay, 1.157-fold (95% CI, 1.123-1.192) higher rates of unique inpatient visits, and 1.339-fold (95% CI, 1.291-1.39) longer lengths of stay in the postacute period. Over the study period, the majority of excess health care costs were estimated to occur in the acute phase (US$21 363 084) compared with the postacute period (US$687 032). Conclusions: There is increased excess risk and rates of health care utilization in the 300 days post-dengue infection when compared with contemporary population-based controls.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.